Cell-to-Cell Variation in p53 Dynamics Leads to Fractional Killing.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cell

• Publication date

  2016-04-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cell.2016.03.025PMID 27062928PMCID PMC5217463
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fractional killing arises from cell-to-cell variability in overcoming a caspase activity threshold

  2015cited by this paper
• Growth Differentiation Factor 15 (GDF-15) Plasma Levels Increase during Bleomycin- and Cisplatin-Based Treatment of Testicular Cancer Patients and Relate to Endothelial Damage

  2015cited by this paper
• Fold change of nuclear NF-κB determines TNF-induced transcription in single cells.

  2014cited by this paper
• Improved vectors and genome-wide libraries for CRISPR screening

  2014cited by this paper
• Parallel Profiling of the Transcriptome, Cistrome, and Epigenome in the Cellular Response to Ionizing Radiation

  2014cited by this paper
• Using optogenetics to interrogate the dynamic control of signal transmission by the Ras/Erk module.

  2013cited by this paper
• Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance

  2013cited by this paper
• Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes

  2013cited by this paper
• The dynamics of signaling as a pharmacological target.

  2013cited by this paper
• A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis

  2013cited by this paper
• Cellular heterogeneity and molecular evolution in cancer.

  2013cited by this paper
• Cancer drug resistance: an evolving paradigm

  2013cited by this paper
• Cisplatin causes cell death via TAB1 regulation of p53/MDM2/MDMX circuitry

  2013cited by this paper
• Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer

  2013cited by this paper
• Rate of environmental change determines stress response specificity

  2013cited by this paper
• The p53 response in single cells is linearly correlated to the number of DNA breaks without a distinct threshold

  2013cited by this paper
• Another fork in the road—life or death decisions by the tumour suppressor p53

  2013cited by this paper
• Encoding and decoding cellular information through signaling dynamics.

  2013cited by this paper
• Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells

  2012cited by this paper
• Targeting IAP proteins for therapeutic intervention in cancer

  2012influential reference
• Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks.

  2012cited by this paper
• p53 Dynamics Control Cell Fate

  2012cited by this paper
• Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment.

  2011cited by this paper
• Stimulus-dependent dynamics of p53 in single cells

  2011cited by this paper
• Signal-dependent dynamics of transcription factor translocation controls gene expression

  2011cited by this paper
• Temporal competition between differentiation programs determines cell fate choice

  2011cited by this paper
• The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs.

  2011cited by this paper
• A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations.

  2010cited by this paper
• Basal dynamics of p53 reveal transcriptionally attenuated pulses in cycling cells.

  2010cited by this paper
• A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

  2010cited by this paper
• Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy.

  2009cited by this paper
• Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis

  2009cited by this paper
• SnapShot: p53 posttranslational modifications.

  2008cited by this paper
• The genetics of the p53 pathway, apoptosis and cancer therapy

  2008cited by this paper
• Acetylation is indispensable for p53 activation.

  2008cited by this paper
• Dynamic Proteomics of Individual Cancer Cells in Response to a Drug

  2008cited by this paper
• Transcriptional control of human p53-regulated genes

  2008cited by this paper
• Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles

  2007cited by this paper
• IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.

  2007cited by this paper
• IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.

  2007cited by this paper
• Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation.

  2007cited by this paper
• MDM2 inhibitors for cancer therapy.

  2007cited by this paper
• Genetic knockouts and knockins in human somatic cells

  2007cited by this paper
• Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA

  2007cited by this paper
• Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy

  2007cited by this paper
• The resurgence of platinum-based cancer chemotherapy

  2007cited by this paper
• IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy‐induced overexpression of multidrug resistance genes

  2006cited by this paper
• Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis.

  2006cited by this paper
• Regulation of PUMA-α by p53 in cisplatin-induced renal cell apoptosis

  2006cited by this paper
• Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei

  2006cited by this paper
• Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.

  2006cited by this paper
• Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis.

  2006cited by this paper
• In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

  2004cited by this paper
• Cellular Inhibitor of Apoptosis 1 and 2 Are Ubiquitin Ligases for the Apoptosis Inducer Smac/DIABLO*

  2003cited by this paper
• The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation.

  2002cited by this paper
• PUMA induces the rapid apoptosis of colorectal cancer cells.

  2001cited by this paper
• ASPP proteins specifically stimulate the apoptotic function of p53.

  2001cited by this paper
• PUMA, a novel proapoptotic gene, is induced by p53.

  2001cited by this paper
• ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas.

  2000cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells.

  1996cited by this paper
• Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes

  1996cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993influential reference

• p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.

  2026cites this paper
• NF-κB transcriptionally enhances p53 accumulation dynamics hampering DNA repair

  2026cites this paper
• Novel Therapy Modalities Combining Photodynamic Therapy and Liposomal Cisplatin for Pancreatic Cancer Treatments

  2025cites this paper
• Data-driven dynamic modelling identifies polyploidisation as key process in cell cycle progression upon DNA damage

  2025cites this paper
• Reduced EIF6 dosage attenuates TP53 activation in models of Shwachman-Diamond syndrome

  2025cites this paper
• Circumventing glioblastoma resistance to temozolomide through optimal drug combinations designed by systems pharmacology and machine learning

  2025cites this paper
• A computational workflow for assessing drug effects on temporal signaling dynamics reveals robustness in stimulus-specific NFκB signaling

  2025cites this paper
• Transition between cell states of sensitivity reveals molecular vulnerability of drug-tolerant cells

  2025cites this paper
• A computational workflow for assessing drug effects on temporal signaling dynamics reveals robustness in stimulus-specific NFκB signaling

  2025cites this paper
• Single-cell dynamics reveal a stress-induced decision between hypertrophy and apoptosis in neonatal rat cardiomyocytes

  2025cites this paper
• Single-cell transcriptomics uncovers that cell-to-cell communication controls p53 activation

  2025cites this paper
• Unlocking the Potential of Single-Cell Omics.

  2025cites this paper
• BESTDR: Bayesian quantification of mechanism-specific drug response in cell culture

  2025cites this paper
• Pharmacokinetic-pharmacodynamic-efficacy modeling of the MDM2 inhibitor brigimadlin in glioblastoma patient-derived xenografts

  2025cites this paper
• CloVarS: a simulation of single-cell clonal variability

  2025cites this paper
• JNK activation dynamics drive distinct gene expression patterns over time mediated by mRNA stability

  2025cites this paper
• Decoding stimulus-specific regulation of promoter activity of p53 target genes

  2025cites this paper
• Pulsed stimuli enable p53 phase resetting to synchronize single cells and modulate cell fate

  2025cites this paper
• Glycogen stores mediated by the p53-GYS1 feedback circuit engenders platinum resistance in ovarian clear cell carcinoma

  2025cites this paper
• Integrating QSP and ML to Facilitate Drug Development and Personalized Medicine.

  2025cites this paper
• Using the simple telegraph model to decipher transcriptional burst regulation across genome-wide data

  2025cites this paper
• Linking signaling dynamics and cell fate decisions through single-cell imaging: evidence and challenges

  2025cites this paper
• Measuring FOXO Nuclear Shuttling Dynamics by Fluorescence Microscopy.

  2025cites this paper
• Single-cell dynamics reveal a stress-induced decision between cardiomyocyte hypertrophy and apoptosis

  2025cites this paper
• Mathematical Modeling of Cell Death and Survival: Toward an Integrated Computational Framework for Multi-Decision Regulatory Dynamics

  2025cites this paper
• JNK activation dynamics drive distinct gene expression patterns over time mediated by mRNA stability

  2025cites this paper
• Decoding the Central Dogma: Quantitative Insights into Transcription and Translation Dynamics in the p53-Mediated DNA Damage Response.

  2025cites this paper
• Cell Confluency Affects p53 Dynamics in Response to DNA Damage.

  2025cites this paper
• Leveraging chromatin packing domains to target chemoevasion in vivo

  2025cites this paper
• Inertial effect of cell state velocity on the quiescence-proliferation fate decision

  2024cites this paper
• Bioinformatic analysis of the molecular targets of curcumin in colorectal cancer.

  2024cites this paper
• Oncofetal MCB1 Is a Functional Biomarker for HCC Personalized Therapy

  2024cites this paper
• Extrinsic fluctuations in the p53 cycle.

  2024cites this paper
• Leveraging chromatin packing domains to target chemoevasion in vivo

  2024cites this paper
• The Role and Efficacy of JNK Inhibition in Inducing Lung Cancer Cell Death Depend on the Concentration of Cisplatin

  2024cites this paper
• Functional genomic screens with death rate analyses reveal mechanisms of drug action

  2024cites this paper
• Functional consequences of a p53-MDM2-p21 incoherent feedforward loop

  2024cites this paper
• Understanding the complexity of p53 in a new era of tumor suppression.

  2024cites this paper
• Synthetic protein circuits for programmable control of mammalian cell death

  2024cites this paper
• Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation

  2024cites this paper
• ARTS and small-molecule ARTS mimetics upregulate p53 levels by promoting the degradation of XIAP

  2024cites this paper
• Construction of a Waddington-like landscape model that can guide clinical exploration of p53-dynamics-activating parameters in the face of divergent p53 dynamics

  2024cites this paper
• Machine learning and bioinformatic analyses link the cell surface receptor transcript levels to the drug response of breast cancer cells and drug off-target effects

  2024cites this paper
• Determinants of p53 DNA binding, gene regulation, and cell fate decisions

  2024cites this paper
• Single-Cell Time-Resolved Metabolomics and Lipidomics Reveal Apoptotic and Ferroptotic Heterogeneity during Foam Cell Formation.

  2024cites this paper
• Quantifying cell fate change under different stochastic gene activation frameworks

  2024cites this paper
• Complex p53 dynamics regulated by miR-125b in cellular responses to reactive oxidative stress and DNA damage

  2024cites this paper
• Survival Resonances during Fractional Killing of Cell Populations.

  2024cites this paper
• CloVarS: a simulation of single-cell clonal variability

  2024cites this paper
• On the Implemention of the System-Biological Approach in Modeling the Functioning of Degenerative Diseases Biomarkers

  2023cites this paper
• p53 controls choice between apoptotic and non-apoptotic death following DNA damage

  2023cites this paper
• Emerging role and therapeutic implications of p53 in intervertebral disc degeneration

  2023cites this paper
• Pulsed stimuli entrain p53 to synchronize single cells and modulate cell-fate determination

  2023cites this paper
• Apoptotic signaling: Beyond cell death.

  2023cites this paper
• Suppression of E6 Oncogene Induces Apoptosis in CaSki Cervical Cancer Cells

  2023cites this paper
• Permission to pass: on the role of p53 as a gatekeeper for aneuploidy

  2023cites this paper
• p53 and p21 dynamics encode single-cell DNA damage levels, fine-tuning proliferation and shaping population heterogeneity

  2023cites this paper
• SCML2 contributes to tumor cell resistance to DNA damage through regulating p53 and CHK1 stability

  2023cites this paper
• Managing Cancer and Living Meaningfully (CALM) alleviates chemotherapy related cognitive impairment (CRCI) in breast cancer survivors: A pilot study based on resting‐state fMRI

  2023cites this paper
• Mixed-Feedback Architectures for Precise Event Timing Through Stochastic Accumulation of Biomolecules

  2023cites this paper
• The mechanism accounting for DNA damage strength modulation of p53 dynamical properties

  2023cites this paper
• Keratin 17 Impacts Global Gene Expression and Controls G2/M Cell Cycle Transition in Ionizing Radiation-Induced Skin Damage.

  2023cites this paper
• Inertial effect of cell state velocity on the quiescence-proliferation fate decision in breast cancer

  2023cites this paper
• Single-cell time-resolved multi-omics reveal apoptotic and ferroptotic heterogeneity during foam cell formation

  2023cites this paper
• Mathematical modeling of regulatory networks of intracellular processes – Aims and selected methods

  2023cites this paper
• Outlook on the Security and Potential Improvements of CRISPR–Cas9

  2023cites this paper
• Modeling Cellular Signaling Variability Based on Single-Cell Data: The TGFβ-SMAD Signaling Pathway.

  2023cites this paper
• FOXO nuclear shuttling dynamics are stimulus-dependent and correspond with cell fate

  2023cites this paper
• Encoding and Decoding of p53 Dynamics in Cellular Response to Stresses

  2023influential citation
• p53-dependent DNA repair during the DNA damage response requires actin nucleation by JMY

  2023cites this paper
• Hsp70‐Bim incoherent feedforward loop contributes to cell‐fate heterogeneity and fractional killing

  2023cites this paper
• Divergent Molecular and Cellular Responses to Low and High-Dose Ionizing Radiation

  2022cites this paper
• Coordination of MAPK and p53 dynamics in the cellular responses to DNA damage and oxidative stress

  2022influential citation
• Endogenous and imposed determinants of apoptotic vulnerabilities in cancer.

  2022cites this paper
• A Machine Learning and Bioinformatic Analysis Reveals an Associated between Cell Surface Receptor Transcript Levels with Drug Response of Breast Cancer Cells and the Drug Off-Target Effects

  2022cites this paper
• Interplay of p53 and XIAP protein dynamics orchestrates cell fate in response to chemotherapy

  2022influential citation
• When cell death goes wrong: inflammatory outcomes of failed apoptosis and mitotic cell death

  2022cites this paper
• Application of Sensitivity Analysis to Discover Potential Molecular Drug Targets

  2022cites this paper
• Mathematical Models of Death Signaling Networks

  2022cites this paper
• Controlling Cancer Cell Death Types to Optimize Anti-Tumor Immunity

  2022cites this paper
• Live-cell imaging and mathematical analysis of the “community effect” in apoptosis

  2022cites this paper
• Enhanced expression of p21 promotes sensitivity of melanoma cells towards targeted therapies

  2022cites this paper
• Development of a fluorescence reporter system to quantify transcriptional activity of endogenous p53 in living cells

  2022cites this paper
• Modeling single-cell phenotypes links yeast stress acclimation to transcriptional repression and pre-stress cellular states

  2022influential citation
• BNIP3 Upregulation Characterizes Cancer Cell Subpopulation With Increased Fitness and Proliferation

  2022cites this paper
• The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy

  2022cites this paper
• p53 directs leader cell behavior, migration, and clearance during epithelial repair

  2022cites this paper
• Suppression of the long non-coding RNA LINC01279 triggers autophagy and apoptosis in lung cancer by regulating FAK and SIN3A

  2022cites this paper
• Regulatory strategies to schedule threshold crossing of protein levels at a prescribed time

  2022cites this paper
• Signalling dynamics, cell decisions, and homeostatic control in health and disease

  2022cites this paper
• A Bioinformatics Analysis Reveals that the Transcription Levels of Cell Surface Receptor Encoding Genes are Associated with the Drug Response of Breast Cancer Cells and the Drug Off-Target Effects

  2022cites this paper
• Modeling isogenic cancer cell response upon varying TRAIL stimulations to decipher the kinetic determinants of cell fate decision

  2022cites this paper
• Cell-to-cell variability in inducible Caspase9-mediated cell death

  2021cites this paper
• Mutagenic Consequences of Sublethal Cell Death Signaling

  2021cites this paper
• The Role of p53 Signaling in Colorectal Cancer

  2021cites this paper
• In-Tether Chiral Center Induced Helical Peptide Modulators Target p53-MDM2/MDMX and Inhibit Tumor Growth in Cancer Stem Cell

  2021cites this paper
• The Multifaceted Role of Plasminogen in Cancer

  2021cites this paper
• Molecular pathways in the development of HPV-induced cervical cancer

  2021cites this paper
• Spike-in normalization for single-cell RNA-seq reveals dynamic global transcriptional activity mediating anticancer drug response

  2021cites this paper
• p53 dynamics vary between tissues and are linked with radiation sensitivity

  2021cites this paper